Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating TAK-925 in healthy volunteers and narcolepsy patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• TAK-925

Snippet

Sponsor: Takeda | Conditions: Healthy Participants, Narcolepsy | Phase 1 | Status: COMPLETED | Results posted: 2020-12-08